"Our study investigated whether PET imaging could detect spared nerve ... such as spinal cord injuries, multiple sclerosis, traumatic brain injury, and even some dementias," noted Pedro Brugarolas ...

Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

progressive multiple sclerosis, and chronic pain. In December 2024, the company dosed the first subject cohort in the Phase Ib positron emission tomography (PET) trial of brain-penetrant small ...

The researchers repurposed the drug edaravone, an antioxidant used to treat amyotrophic lateral sclerosis (ALS), as a probe to be used with central nervous system PET imaging. With this technique ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

Currently, patients with clinically isolated syndrome (CIS) and brain lesions on MRI suggestive of multiple sclerosis (MS), are offered a confirmatory MRI scan after 6 months. Researchers in Italy ...

MRI is a key modality for assessing multiple sclerosis (MS) disease course and response to treatment. Current conventional MRI is limited by repositioning error, and methods of quantifying lesion ...